(Q33959664)

30 July 2017

title

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor (English)

1 reference

30 July 2017

Shaun Jordan

1

1 reference

30 July 2017

Vuk Koprivica

2

1 reference

30 July 2017

Ruoyan Chen

3

1 reference

30 July 2017

Katsura Tottori

4

1 reference

30 July 2017

Tetsuro Kikuchi

5

1 reference

30 July 2017

C Anthony Altar

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

European Journal of Pharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

441

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

137-140

1 reference

Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

The role of serotonin in antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901532-7

10.1016/S0014-2999(02)01532-7

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference